SEC Form 4 · accession 0001209191-15-087417
Microbot Medical Inc. · MBOT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Blair Stratton
Officer — General Counsel
Period of report
Dec 29, 2015
Accepted (ET)
Dec 30, 2015 · 5:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000883975
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 29, 2015 | S | 104,549 | $0.4512 | D | 556,525 | D | |
| Common StockF3 | holding | — | — | — | 36,081 | I | By 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The $0.4512 per share price was the weighted average price of open market sales by Mr. Stratton on 12/29/2015. Actual prices ranged from $0.4411 per share to $0.4699 per share. Mr. Stratton will provide full information about the number of shares sold at each price, upon request by the SEC, the issuer or any security holder of the issuer.
- F2Includes (1) 140,000 restricted stock units, with 70,000 of these vesting on each of May 24, 2016 and May 24, 2017; (2) 32,500 restricted stock units vesting on January 27, 2016; (3) 240,000 restricted stock units, with 80,000 of these vesting on each of January 8, 2016, January 8, 2017 and January 8, 2018; and (4) 80,000 restricted stock units with performance based vesting.
- F3Shares held in 401(k) account, in accordance with issuer's employer-match policies.